Argos Therapeutics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
23,921.60
53,305.90
74,788.50
53,028.10
40,577.50
Depreciation, Depletion & Amortization
611.40
566.10
680.40
952.30
967.90
Other Funds
47,409.90
-
12,500.00
-
-
Funds from Operations
19,550.20
48,940.90
67,620.70
46,760.80
28,705.70
Changes in Working Capital
1,294.40
3,700.10
6,600.00
6,083.90
6,719.10
Net Operating Cash Flow
18,255.70
45,240.80
61,020.70
40,677.00
35,424.90
Capital Expenditures
596.50
1,097.80
9,686.60
15,330.00
3,674.40
Sale of Fixed Assets & Businesses
50.80
2.00
-
-
3,250.60
Purchase/Sale of Investments
9,510.90
5,368.50
18,609.80
1,003.40
740.00
Net Investing Cash Flow
10,056.60
7,789.30
8,923.20
14,326.50
316.30
Issuance/Reduction of Debt, Net
6,899.10
11,998.70
416.50
1,725.30
18,160.30
Net Financing Cash Flow
53,403.50
56,965.90
21,061.80
101,810.00
2,684.20
Net Change in Cash
25,083.10
3,925.60
31,060.40
46,810.20
37,784.50
Free Cash Flow
18,852.20
46,338.60
70,707.30
56,006.90
39,099.20
Change in Capital Stock
905.40
44,967.20
8,978.30
103,535.30
15,476.10
Exchange Rate Effect
8.10
10.20
24.80
3.70
8.20
Other Uses
-
1,325.00
-
-
-
About Argos Therapeutics
View Profile
